Literature DB >> 1609726

Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients.

E Levine1, J J Grantham.   

Abstract

Although renal calculi and cyst calcifications occur commonly in patients with autosomal dominant polycystic kidney disease (ADPKD), their true frequency is unknown because it is difficult to distinguish between the two with excretory urography and sonography. A detailed analysis of renal calcifications in ADPKD based on CT findings has not been performed. Accordingly, we retrospectively evaluated clinical and CT findings in 84 patients with ADPKD to determine the frequency of calculi and cyst calcifications, the relationship of these abnormalities to symptoms, and possible factors in their pathogenesis. Of the 84 patients, 53 had both IV contrast-enhanced and unenhanced CT scans and 31 had unenhanced scans only. We examined unenhanced CT scans of all 84 patients for renal calcifications. However, we classified renal calcifications into stones and cyst calcifications in only the 53 patients, because it is often difficult to distinguish between the two when only unenhanced scans are available. Of 84 patients, 18 (21%) had passed renal calculi or had stones treated surgically and 42 (50%) had renal calcifications on CT. Of the 53 patients who had both enhanced and unenhanced CT scans, 19 (36%) had renal calculi on CT. Patients with stones had significantly higher frequencies of previous flank pain (68% vs 35%) and of urinary tract infections (63% vs 18%) than did those without calculi. Cyst calcifications occurred in 13 (25%) of 53 patients and were probably a consequence of cyst hemorrhage. Cyst calcifications were found significantly more often in older patients with larger kidneys and worse renal function. We conclude that renal stones have a high rate of occurrence among patients with ADPKD and are a significant cause of morbidity in this disorder. Cyst calcification is also common in patients with ADPKD, particularly those with more advanced cystic disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1609726     DOI: 10.2214/ajr.159.1.1609726

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.

Authors:  Matteo Bargagli; Nasser A Dhayat; Manuel Anderegg; Mariam Semmo; Uyen Huynh-Do; Bruno Vogt; Pietro Manuel Ferraro; Daniel G Fuster
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 8.237

Review 2.  Lithiasis in cystic kidney disease and malformations of the urinary tract.

Authors:  G Gambaro; A Fabris; D Puliatta; A Lupo
Journal:  Urol Res       Date:  2006-01-14

3.  Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?

Authors:  Aneesh Srivastava; Rajesh Bansal; Alok Srivastava; Samit Chaturvedi; Priyadarshi Ranjan; M S Ansari; Abhishek Yadav; Rakesh Kapoor
Journal:  Int Urol Nephrol       Date:  2011-11-20       Impact factor: 2.370

4.  Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Koki Mise; Toshiharu Ueno; Keiichi Sumida; Masayuki Yamanouchi; Noriko Hayami; Junichi Hoshino; Masahiro Kawada; Aya Imafuku; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi
Journal:  J Am Soc Nephrol       Date:  2015-11-30       Impact factor: 10.121

5.  Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.

Authors:  Kevin S Heffernan; Jeffrey T Kuvin; Mark J Sarnak; Ronald D Perrone; Dana C Miskulin; Darya Rudym; Priya Chandra; Richard H Karas; Vandana Menon
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

6.  Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease.

Authors:  Renato Ribeiro Nogueira Ferraz; Jonathan Mackowiak Fonseca; Gregory George Germino; Luiz Fernando Onuchic; Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2014-05-10       Impact factor: 3.436

7.  Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes.

Authors:  Almira Kurbegovic; Olivier Côté; Martin Couillard; Christopher J Ward; Peter C Harris; Marie Trudel
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

8.  Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.

Authors:  Dana Rizk; Claudine Jurkovitz; Emir Veledar; Susan Bagby; Deborah A Baumgarten; Frederic Rahbari-Oskoui; Theodore Steinman; Arlene B Chapman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

9.  The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease.

Authors:  A Idrizi; M Barbullushi; E Petrela; S Kodra; A Koroshi; N Thereska
Journal:  Hippokratia       Date:  2009-07       Impact factor: 0.471

10.  Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Authors:  José L Nishiura; Rodrigo F C A Neves; Samara R M Eloi; Susan M L F Cintra; Sergio A Ajzen; Ita P Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.